Log In

Part Description

LP417540-4   SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

LOINC Names Get Info

Fully-Specified Name
SARS coronavirus 2 Ag:PrThr:Pt:Nasopharynx:Ord:IF
Long Common Name
SARS-CoV-2 (COVID-19) Ag [Presence] in Nasopharynx by Immunofluorescence
Short Name
SARS-CoV-2 Ag Nasoph Ql IF
Display Name
SARS-CoV-2 (COVID-19) Ag IF Ql (Nph)
Consumer Name Alpha Get Info
SARS-CoV-2 (COVID-19) antigen, Nasopharynx

Part Model Get Info

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.75
Last Updated
Version 2.82 (NAM)
Change Reason
Release 2.78: PROPERTY: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.;
Order vs. Observation
Both

Member of these Groups Get Info

LOINC GroupGroup Name
LG51017-8SARSCoV2 detection

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)SARS-CoV-2 Ag:Přítomnost nebo práh:Časový bod:Nosohltan:Ordinální:Imunofluoresecence (IF)
de-DEGerman (Germany)SARS-Coronavirus 2 Ag:Nachweis oder Schwellenwert:Zeitpunkt:Nasopharynx:Ordinal:Immunfluoreszenztest
el-GRGreek (Greece)Κορωνοϊός SARS 2 Αντιγόνο:PrThr:Pt:Ρινοφάρυγγας:Ord:Ανοσοφθορισμός
Synonyms: MICRO Ord PrThr Pt Ανοσοφθορισμός Αντιγόνο Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2 Ρινοφάρυγγας
es-ESSpanish (Spain)Panel del SARS-CoV-2 (COVID-19) Antígeno:PrThr:Punto temporal:Nasofaringe:Ord:Inmunofluorescencia (IF)
fr-FRFrench (France)Coronavirus SARS-CoV-2 Ag:Présence/Seuil:Ponctuel:Nasopharyngée:Qualitatif:Immunofluorescence
it-ITItalian (Italy)SARS coronavirus 2, Ag:PrThr:Pt:Nasofaringe:Ord:IF
Synonyms: Coronavirus della SARS Immunofluorescenza (IF) Microbiologia Presenza o Soglia Punto nel tempo (episodio) Rinofaringe SARS-CoV-2 (COVID-19)
zh-CNChinese (China)SARS 冠状病毒 2 抗原:存在情况或阈值:时间点:鼻咽部:序数型:免疫荧光法
Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ag Ag IF DFA IFA法;IF法;抗补体免疫荧光法;时间分辨荧光法;荧光原位杂交技术;荧光原位杂交法;荧光抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值） 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 抗原免疫荧光检测 抗原免疫荧光测定 时刻;随机;随意;瞬间 直接免疫荧光分析 直接免疫荧光检测 直接免疫荧光测定 顽颡;鼻咽

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=101928-0